Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel AR antagonist ZR-291 exhibits potent preclinical activity in prostate cancer

Dec. 4, 2009

Small-molecule compound BRA-101 reduces DSS-induced murine colitis

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

Prasugrel more effective than clopidogrel in CAD patients with type 2 diabetes

Dec. 4, 2009

New camptothecin conjugate evaluated in phase I trial in advanced solid tumors

Dec. 4, 2009

GSK-2126458 shows potent preclinical antitumor activity; phase I trial under way

Dec. 4, 2009

Data from phase I study on AS-703569 disclosed at 2009 AACR-NCI-EORTC meeting

Dec. 3, 2009

Interim data presented from AV-412 phase I trial in advanced solid tumors

Dec. 3, 2009

TRIN-2755 exhibits antitumor activity in multiple xenograft mouse models

Dec. 3, 2009

MK-1775 exhibits synergism with gemcitabine in pancreatic tumors in vivo

Dec. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.